Second Primary Malignancies in the Head and Neck Cancer Patient

Abstract

With improvements in locoregional control, the problem of second primary malignancies is rapidly being pushed to the forefront of head and neck oncology. While the constant long-term risk for the head and neck cancer patient has been well established, efforts at prevention, early detection, and treatment have been somewhat futile. Recent advances in genetic predisposition, biomarkers, photodiagnostic imaging, and differentiation therapy may soon offer improved outcomes. The literature is reviewed and current research is presented regarding the history, epidemiology, etiology, diagnosis, and treatment of second primary malignancies.

Keywords

head and neck neoplasms mutagen sensitivity photodynamic therapy retinoids second primary malignancies

Get full access to this article

View all access options for this article.

References

Steele

Winchester

Menck

Murphy

. Clinical highlights from the national cancer data base: 1993. CA Cancer J Clin 1993; 43: 71–82.

DeVries

VanZandwijk

Pastorino

. The Euroscan study. Br J Cancer 1991; 64: 985–9.

Cooper

Pajak

Rubin

. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449–56.

Lippman

Hong

. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17: 691–4.

Warren

Gates

. Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 1932; 16: 1358–414.

Moertel

. Multiple primary malignant neoplasms: Historical perspectives. Cancer 1977; 40: 1786–92.

Gluckman

Crissman

Donegan

. Multicentric squamous-cell carcinoma of the upper aerodigestive tract. Head Neck Surg 1980; 3: 90–6.

Benner

Lippman

Hong

. Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res 1992; 52(suppl): 2758S–2763S.

Lippman

Benner

Hong

. Chemopreventive strategies in lung carcinogenesis. Chest 1993; 103: 15S–19S.

10.

Spitz

Fueger

Beddingfield

. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 1989; 49: 4626–8.

11.

Schantz

Spitz

Hsu

. Mutagen sensitivity in patients with head and neck cancers: A biologic marker for risk of multiple primary malignancies. JNCI 1990; 82: 1773–5.

12.

Hsu

Spitz

Schantz

. Mutagen sensitivity: A biologic marker of cancer susceptibility. Cancer Epidemiol Bio-markers Prev 1991; 1: 83–9.

13.

Slaughter

Southwick

Smejkal

. “Field cancerization” in oral stratified squamous epithelium. Cancer 1953; 6: 963–8.

14.

Park

Shin-Park

. Multiple primary malignancies of the upper aerodigestive tract. Resident Staff Phys 1992; 38: 49–54.

15.

Larson

Adams

Fattah

. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990; 103: 14–24.

16.

VanBodegom

Wagenaar

Corrin

Baak

JPA

Berkel

Vanderschueren

RGJ

. Second primary lung cancer: Importance of long term follow up. Thorax 1989; 44: 788–93.

17.

Shields

Humphrey

Higgins

Keehn

. Long-term survivors after resection of lung carcinoma. J Thorac Cardiovasc Surg 1978; 76: 439–42.

18.

Auerbach

Stout

Hammond

Garfinkel

. Multiple primary bronchial carcinomas. Cancer 1967; 20: 699–705.

19.

Watson

. Cancer of the esophagus, some etiological considerations. Am J Roentgenol 1939; 41: 420–4.

20.

Okumura

Aruga

Inohara

. Endoscopic examination of the upper gastrointestinal tract for the presence of second primary cancers in head and neck cancer patients. Acta Otolaryngol Suppl (Stockh) 1993(suppl 501): 103–6.

21.

McGuirt

Matthews

Koufman

. Multiple simultaneous tumors in patients with head and neck cancer. Cancer 1982; 50: 1195–9.

22.

Shons

McQuarrie

. Multiple primary epidermoid carcinomas of the upper aerodigestive tract. Arch Surg 1985; 120: 1007–9.

23.

Wagenfeld

DJH

Harwood

Bryce

VanNorstrand

AWP

DeBoer

. Second primary respiratory tract malignant neoplasms in supraglottic carcinoma. Arch Otolaryngol 1981; 107: 135–7.

24.

Panosetti

Luboinski

Mamelle

Richard

. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: A nine-year study. Laryngoscope 1989; 99: 1267–73.

25.

Shikhani

Matanoski

Jones

Kashima

Johns

. Multiple primary malignancies in head and neck cancer. Arch Otolaryngol Head Neck Surg 1986; 112: 1172–9.

26.

Cohn

Peppard

. Multiple primary malignant tumors of the head and neck. Am J Otolaryngol 1980; 1: 411–7.

27.

Tepperman

Fitzpatrick

. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 1981; 2: 547–9.

28.

Grossman

. The incidence and diagnosis of secondary esophageal carcinoma in the head and neck cancer patient Laryngoscope 1989; 99: 1052–6.

29.

Haughey

Gates

Arfken

Harvey

. Metaanalysis of second malignant tumors in head and neck cancer: The case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101: 105–12.

30.

Franco

. Multiple cancers of the upper aero-digestive tract: The challenge of risk factor identification. Cancer Lett 1991; 60: 1–8.

31.

McGuirt

. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer a prospective sequential study and review of the literature. Laryngoscope 1982; 92: 569–76.

32.

Parker

Hill

. Panendoscopy in screening for synchronous primary malignancies. Laryngoscope 1988; 98: 147–9.

33.

Maisel

Vermeersch

. Panendoscopy for second primaries in head and neck cancer. Ann Otol Rhinol Laryngol 1981; 90: 460–4.

34.

Leipzig

Zellmer

Klug

. The role of endoscopy in evaluating patients with head and neck cancer. Arch Otolaryngol 1985; 111: 589–94.

35.

Gluckman

. Synchronous multiple primary lesions of the upper aerodigestive system. Arch Otolaryngol 1979; 105: 597–8.

36.

Robinson

Neugut

Murray

Rennert

. A comparison of the clinical characteristics of first and second primary head and neck cancers. Cancer 1991; 68: 189–92.

37.

Boysen

Lovdal

Tausjo

Winther

. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992; 28: 426–30.

38.

Vikram

Strong

Shah

Spiro

. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984; 6: 734–7.

39.

Decker

Goldstein

. Risk factors in head and neck cancer. N Engl J Med 1982; 306: 1151–5.

40.

Vokes

Weichselbaum

Lippman

Hong

. Head and neck cancer. N Engl J Med 1993; 328: 184–94.

41.

Moore

. Cigarette smoking and cancer of the mouth, pharynx, and larynx. JAMA 1971; 218: 553–8.

42.

Silverman

Gorsky

Greenspan

. Tobacco usage in' patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc 1983; 106: 33–5.

43.

Castigliano

. Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx. J Am Dent Assoc 1968; 77: 580–5.

44.

Shottenfeld

Gantt

Wynder

. The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx and lung: A prospective study. Prev Med 1974; 3: 277–93.

45.

Wynder

Dodo

Bloch

Gantt

Moore

. Epidemiologic investigation of multiple primary cancer of the upper alimentary and respiratory tracts. Cancer 1969; 24: 730–9.

46.

Hsu

Shillitoe

Cherry

Lin

Schantz

Furlong

. Cytogenetic characterization of 20 lymphoblastoid lines derived from human individuals differing in bleomycin sensitivity. In Vitro Cell Dev Biol 1990; 26: 80–4.

47.

Hsu

Johnston

Cherry

. Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis. Int J Cancer 1989; 43: 403–9.

48.

Schantz

Hsu

. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck 1989; 11: 337–42.

49.

Schantz

Hsu

Ainslie

Moser

. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 1989; 262: 3313–5.

50.

DeVries

Drexhage

DeWaal

DeLange

Snow

. Human leukocyte antigens and immunoglobulin allotypes in head and neck cancer patients with and without multiple primary tumors. Cancer 1987; 60: 957–61.

51.

Schantz

Savage

Lee

. Head and neck tumor immunology. In: Jacobs

, ed. Carcinomas of the head and neck: Evaluation and management. Boston, Mass: Kluwer Academic Publishers, 1990: 243–63.

52.

Schantz

Liu

. An immunologic profile of young adults with head and neck cancer. Cancer 1989; 64: 1232–7.

53.

Cortesina

Sacchi

Galeazzi

DeStefani

. Immunology of head and neck cancer: Perspectives. Head Neck 1993; 15: 74–7.

54.

Safai

Diaz

Schwartz

. Malignant neoplasms associated with human immunodeficiency virus infection. CA Cancer J Clin 1992; 42: 74–95.

55.

Broder

Karp

. The expanding challenge of HIV-associated malignancies. CA Cancer J Clin 1992; 42: 69–73.

56.

Epstein

Silverman

. Head and neck malignancies associated with HIV infection. Oral Surg Oral Med Oral Pathol 1992; 73: 193–200.

57.

Dichtel

. Oral manifestations of human immunodeficiency virus infection. Otolaryngol Clin North Am 1992; 25: 1211–26.

58.

Neel

. Routine panendoscopy — Is it necessary every time? Arch Otolaryngol 1984; 110: 531–2.

59.

Schuller

Fritsch

. An assessment of the value of triple endoscopy in the evaluation of head and neck cancer patients. J Surg Oncol 1986; 32: 156–8.

60.

Vrabec

. Multiple primary malignancies of the upper aerodigestive system. Ann Otol Rhinol Laryngol 1979; 88: 846–54.

61.

Shapshay

Hong

Fried

Sismanis

Vaughan

Strong

. Simultaneous carcinomas of the esophagus and upper aerodigestive tract. Otolaryngol Head Neck Surg 1980; 88: 373–7.

62.

Rice

Spiro

. Current concepts in head and neck cancer. USA: American Cancer Society, 1989: 15.

63.

Fontana

Sanderson

Woolner

Taylor

Miller

Muhm

. Lung cancer screening: The Mayo program. J Occup Med 1986; 28: 746–50.

64.

Snow

. Follow-up in patients treated for head and neck cancer how frequent, how thorough and for how long? Eur J Cancer 1992; 28: 315–6.

65.

Shaha

Hoover

Marti

Krespi

. Is routine triple endoscopy cost-effective in head and neck cancer? Am J Surg 1988; 155: 750–3.

66.

Mashberg

. Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: A continuing prospective study of oral cancer III. Cancer 1980; 46: 758–63.

67.

Mashberg

. Final evaluation of tolonium chloride rinse for screening of high risk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 1983; 106: 319–23.

68.

Shiozaki

Tahara

Kobayashi

. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer 1990; 66: 2068–71.

69.

Himmelweit

, ed. The collected papers of Paul Ehrlich. Elmsford, NY: Pergamon Press, 1975.

70.

Schantz

. Experimental head and neck oncology. Curr Opin Oncol 1992; 4: 478–84.

71.

Dabelsteen

Clausen

Mandel

. Aberrant glycosy lation in oral malignant and premalignant lesions. J Oral Pathol Med 1991; 20: 361–8.

72.

Byrne

Thrane

Dabelsteen

. Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas. Cancer 1991; 67: 613–8.

73.

Wolf

Carey

Schmaltz

. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. JNCI 1990; 82: 1566–72.

74.

Estaban

Concha

Delgado

Perez-Ayala

Ruiz-Cabello

Garrido

. Lack of MHC class I antigen and tumor aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer 1990; 62: 1047–51.

75.

Van Heerden

Grant

Gharub

Hay

Ilstrup

. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990; 212: 395–400.

76.

Lydiatt

Savage

Dayman

Liu

Sample

Schantz

. Serologic determinants of survival in patients with head and neck cancer: Validating a clinical prediction model. Laryngoscope 1993; 103: 13–6.

77.

Schantz

Savage

Brown

. Significance of Clq-binding macromolecules within the head and neck cancer patient. Cancer Res 1990; 50: 4349–54.

78.

Dayman

Savage

Ainslie

Liu

Schantz

. Serologic determinants of survival in patients with squamous cell carcinoma of the head and neck. Am J Surg 1990; 160: 434–8.

79.

Schantz

Liu

Taylor

Beddingfield

Weber

. The relationship of circulating IgA to cellular immunity in head and neck cancer patients. Laryngoscope 1988; 98: 671–8.

80.

Ropka

Goodwin

Levine

Sasaki

Kirchner

Cantrell

. Effective head and neck tumor markers. Arch Otolaryngol Head Neck Surg 1991; 117: 1011–4.

81.

Sidransky

VonEschenbach

Tsai

. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991; 252: 706–9.

82.

Sidransky

Tokino

Hamilton

. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102–5.

83.

Sidransky

Boyle

Koch

. Molecular screening: Prospects for a new approach. Arch Otolaryngol Head Neck Surg 1993; 119: 1187–90.

84.

Castro

Saxton

Lufkin

. Future directions of laser phototherapy for diagnosis and treatment of malignancies: Fantasy, fallacy, or reality? Laryngoscope 1991; 101: 1–10.

85.

Castro

Saxton

Fetterman

Castro

Ward

. Phototherapy with argon lasers and rhodamine-123 for tumor eradication. Otolaryngol Head Neck Surg 1988; 98: 581–8.

86.

Donald

Cardiff

Kendall

. Monoclonal antibody-porphyrin conjugate for head and neck cancer: The possible magic bullet. Otolaryngol Head Neck Surg 1991; 105: 781–7.

87.

Alfano

Das

Cleary

Prudente

Celmer

. Light sheds light on cancer — Distinguishing malignant tumors from benign tissues and tumors. Bull NY Acad Med 1991; 67: 143–50.

88.

Alfano

Pradhan

Tang

Das

Yoo

. Optical spectroscopy may offer novel diagnostic approaches for the medical profession. In: Goldman

, ed. Laser non-surgical medicine. Lancaster, Pa: Technomic Publishing, 1990: 55–123.

89.

Das

Glassman

Alfano

. UV fluorescence spectroscopic technique in the diagnosis of breast, ovarian, uterus and cervix cancer. Proceedings of Laser-Tissue Interaction n, Society of Photo-Optical Instrumentation Engineers, 1991;1427: 368–73.

90.

Wong

Caputo

Godwin

Rigas

. Infrared spectroscopy of exfoliated human cervical cells: Evidence of extensive structural changes during carcinogenesis. Proc Natl Acad Sci USA 1991; 88: 10988–92.

91.

Cothren

Richards-Kortum

Sivak

. Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopy. Gastrointest Endosc 1990: 36: 105–11.

92.

Wenig

Kurtzman

DMD

Grossweiner

. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1990; 116: 1267–70.

93.

Gluckman

. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflections on a five year experience. Laryngoscope 1991; 101: 36–42.

94.

Hong

Lippman

Itri

. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795–801.

95.

Lippman

Kessler

Meyskens

. Retinoids as preventive and therapeutic anticancer agents (part I). Cancer Treat Rep 1987; 71: 391–405.

96.

Hong

Endicort

Itri

. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315: 1501–5.

97.

Crile

. Excision of cancer of the head and neck with special reference to the plan of dissection based upon 132 operations. JAMA 1906; 47: 1780–6.